Hot Pursuit     13-Sep-23
Zydus Life rises after receiving EIR report for Ahmedabad-based facility from US FDA
Zydus Lifesciences added 1.90% to Rs 639.60 after the company announced the receipt of EIR report from the USFDA for the inspection conducted at the injectables manufacturing facility at Zydus Biotech Park, Changodar, Ahmedabad.

The inspection, carried out between 5th and 13th of June 2023, was a cGMP Inspection and had ended with NIL observations.

Zydus Lifesciences is a discovery-driven, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The company had reported 109.7% surge in net profit to Rs 1,086.9 crore in Q1 FY24 as compared with Rs 518.3 crore posted in Q1 FY23. Revenue from operations jumped 29.6% to Rs 5,139.6 crore during the quarter as compared with Rs 3,964.4 crore recorded in same quarter last year.

Previous News
  Zydus announces NDA acceptance of Desidustat in China by NMPA
 ( Corporate News - 23-Apr-24   16:06 )
  Zydus Life gets tentative USFDA approval for Letermovir tablets
 ( Hot Pursuit - 23-Mar-24   14:21 )
  Sentynl, a Zydus company, acquires Zokinvy® (Lonafarnib)
 ( Corporate News - 04-May-24   10:42 )
  Zydus receives USFDA approval for Erythromycin Tablets
 ( Corporate News - 01-Sep-23   15:42 )
  Zydus Lifesciences Ltd soars 1.23%, gains for fifth straight session
 ( Hot Pursuit - 21-May-24   13:00 )
  Zydus Life gets USFDA nod for antidepressant drug
 ( Hot Pursuit - 18-Aug-23   12:25 )
  Zydus Lifesciences Ltd spurts 2.36%, rises for third straight session
 ( Hot Pursuit - 17-May-24   13:05 )
  USFDA conducts inspection of Zydus' API site at Changodar, Ahmedabad
 ( Corporate News - 22-Dec-23   19:54 )
  Zydus receives USFDA tentative approval for Edaravone Injection
 ( Corporate News - 14-Mar-24   13:51 )
  Zydus Lifesciences declare Quarterly Result
 ( Corporate News - 09-May-24   13:52 )
  Zydus Lifesciences receives USFDA approval for Ephedrine Sulfate Injection
 ( Corporate News - 17-May-23   11:05 )
Other Stories
  PEL board OKs ad hoc appointments post Rupen Patel's passing
  06-Jul-24   16:41
  Info Edge Q1 FY25 billings climb 11% YoY
  06-Jul-24   15:50
  IndusInd Bank advances climb 16% YoY in Q1 FY25
  06-Jul-24   15:18
  Adani Wilmar reports 13% volume growth in Q1 FY25
  06-Jul-24   14:44
  Tata Motors JLR wholesale rises 5% YoY in Q1
  06-Jul-24   13:01
  Marico's domestic biz sees modest volume growth in Q1
  06-Jul-24   12:25
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
Back Top